Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Lazennec G

Collect these papers and discover other ones on Labmeeting. Learn more.

Emerging roles of chemokines in prostate cancer.

+ cite this

+ View Abstract

Vindrieux D, Escobar P, and Lazennec G

Endocrine-related cancer 16(3):663-73, 2009 Sep - Who cited this? | PubMed ID: 19556286 | Fulltext

Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer.

+ cite this

+ View Abstract

Rial NS, Lazennec G, Prasad AR, Krouse RS, Lance P, and Gerner EW

International journal of cancer. Journal international du cancer 124(10):2270-80, 2009 May 15 - Who cited this? | PubMed ID: 19173296 | Fulltext

CXC Ligand 5 Is an Adipose-Tissue Derived Factor that Links Obesity to Insulin Resistance.

+ cite this

+ View Abstract

Chavey C, Lazennec G, Lagarrigue S, Clapé C, Iankova I, Teyssier J, Annicotte JS, Schmidt J, Mataki C, Yamamoto H, Sanches R, Guma A, Stich V, Vitkova M, Jardin-Watelet B, Renard E,

(show remaining authors)

Cell metabolism 9(4):339-49, 2009 Apr - Who cited this? | PubMed ID: 19356715 | Fulltext

Interleukin-8 expression is regulated by histone deacetylases through the NF-{kappa}B pathway in breast cancer.

+ cite this

+ View Abstract

Chavey C, Muhlbauer M, Bossard C, Freund A, Durand S, Jorgensen C, Jobin C, and Lazennec G

Molecular pharmacology, 2008 Jul 30 - Who cited this? | PubMed ID: 18669446 | Fulltext

Concise review: adult multipotent stromal cells and cancer: risk or benefit?.

+ cite this

+ View Abstract

Lazennec G and Jorgensen C

Stem cells (Dayton, Ohio) 26(6):1387-94, 2008 Jun - Who cited this? | PubMed ID: 18388305 | Fulltext

[Multipotent stromal cells: controversial impact on tumor development and metastasis].

+ cite this

Apparailly F, Jorgensen C, and Lazennec G

Medecine sciences : M/S 24(4):359-60, 2008 Apr - Who cited this? | PubMed ID: 18405628 | Fulltext

CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.

+ cite this

+ View Abstract

Amura CR, Brodsky KS, Gitomer B, McFann K, Lazennec G, Nichols MT, Jani A, Schrier RW, and Doctor RB

American journal of physiology. Cell physiology 294(3), 2008 Mar - Who cited this? | PubMed ID: 18199703 | Fulltext

Phosphorylation of Activation Function-1 Regulates Proteasome-Dependent Nuclear Mobility and E6-Associated Protein Ubiquitin Ligase Recruitment to the Estrogen Receptor {beta}.

+ cite this

+ View Abstract

Picard N, Charbonneau C, Sanchez M, Licznar A, Busson M, Lazennec G, and Tremblay A

Molecular endocrinology (Baltimore, Md.) 22(2):317-30, 2008 Feb - Who cited this? | PubMed ID: 17962381 | Fulltext

Expression of estrogen receptors alpha and beta in early steps of human breast carcinogenesis.

+ cite this

Roger P, Esslimani-Sahla M, Delfour C, Lazennec G, Rochefort H, and Maudelonde T

Advances in experimental medicine and biology 617:139-48, 2008 - Who cited this? | PubMed ID: 18497038 | Fulltext

RelB, a new partner of aryl hydrocarbon receptor-mediated transcription.

+ cite this

+ View Abstract

Vogel CF, Sciullo E, Li W, Wong P, Lazennec G, and Matsumura F

Molecular endocrinology (Baltimore, Md.) 21(12):2941, 2007 Dec - Who cited this? | PubMed ID: 17823304 | Fulltext

Chemokines: novel targets for breast cancer metastasis.

+ cite this

+ View Abstract

Ali S and Lazennec G

Cancer metastasis reviews 26(3-4):401-20, 2007 Dec - Who cited this? | PubMed ID: 17717637 | Fulltext

CXC chemokines located in the 4q21 region are up-regulated in breast cancer.

+ cite this

+ View Abstract

Bièche I, Chavey C, Andrieu C, Busson M, Vacher S, Le Corre L, Guinebretière JM, Burlinchon S, Lidereau R, and Lazennec G

Endocrine-related cancer 14(4):1039-52, 2007 Dec - Who cited this? | PubMed ID: 18045955 | Fulltext

High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

+ cite this

+ View Abstract

Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau R, and de Roux N

Endocrine-related cancer 14(3):691-702, 2007 Sep - Who cited this? | PubMed ID: 17914099 | Fulltext

Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.

+ cite this

+ View Abstract

Henriquet C, Gougat C, Combes A, Lazennec G, and Mathieu M

Lung cancer (Amsterdam, Netherlands) 56(2):167-74, 2007 May - Who cited this? | PubMed ID: 17207890 | Fulltext

Oestrogen receptor negative breast cancers exhibit high cytokine content.

+ cite this

+ View Abstract

Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, Roques S, and Lazennec G

Breast cancer research : BCR 9(1):R15, 2007 - Who cited this? | PubMed ID: 17261184 | Fulltext

ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors.

+ cite this

+ View Abstract

Duong V, Licznar A, Margueron R, Boulle N, Busson M, Lacroix M, Katzenellenbogen BS, Cavaillès V, and Lazennec G

Oncogene 25(12):1799-806, 2006 Mar 16 - Who cited this? | PubMed ID: 16158045 | Fulltext

Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.

+ cite this

+ View Abstract

Lazennec G

Cancer letters 231(2):151-7, 2006 Jan 18 - Who cited this? | PubMed ID: 16399219 | Fulltext

Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.

+ cite this

+ View Abstract

Hervé MA, Meduri G, Petit FG, Domet TS, Lazennec G, Mourah S, and Perrot-Applanat M

The Journal of endocrinology 188(1):91-9, 2006 Jan - Who cited this? | PubMed ID: 16394178 | Fulltext

The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene.

+ cite this

+ View Abstract

Annicotte JS, Chavey C, Servant N, Teyssier J, Bardin A, Licznar A, Badia E, Pujol P, Vignon F, Maudelonde T, Lazennec G, Cavailles V, and Fajas L

Oncogene 24(55):8167-75, 2005 Dec 8 - Who cited this? | PubMed ID: 16091743 | Fulltext

Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8.

+ cite this

+ View Abstract

Kim SW, Hayashi M, Lo JF, Fearns C, Xiang R, Lazennec G, Yang Y, and Lee JD

Cancer research 65(19):8784, 2005 Oct 1 - Who cited this? | PubMed ID: 16204048 | Fulltext

Retraction: article on estrogen receptor beta in ovarian carcinogenesis.

+ cite this

Lazennec G

Cancer research 65(12):5480, 2005 Jun 15 - Who cited this? | PubMed ID: 15966130 | Fulltext

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.

+ cite this

+ View Abstract

Bardin A, Boulle N, Lazennec G, Vignon F, and Pujol P

Endocrine-related cancer 11(3):537-51, 2004 Sep - Who cited this? | PubMed ID: 15369453 | Fulltext

Involvement of estrogen receptor beta in ovarian carcinogenesis.

+ cite this

+ View Abstract

Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P, and Lazennec G

Cancer research 64(16):5861-9, 2004 Aug 15 - Who cited this? | PubMed ID: 15313930 | Fulltext

Mechanisms underlying differential expression of interleukin-8 in breast cancer cells.

+ cite this

+ View Abstract

Freund A, Jolivel V, Durand S, Kersual N, Chalbos D, Chavey C, Vignon F, and Lazennec G

Oncogene 23(36):6105-14, 2004 Aug 12 - Who cited this? | PubMed ID: 15208657 | Fulltext

Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis.

+ cite this

+ View Abstract

Cheng J, Lee EJ, Madison LD, and Lazennec G

FEBS letters 566(1-3):169-72, 2004 May 21 - Who cited this? | PubMed ID: 15147889 | Fulltext

Identification of genes involved in growth inhibition of breast cancer cells transduced with estrogen receptor.

+ cite this

+ View Abstract

Licznar A, Caporali S, Lucas A, Weisz A, Vignon F, and Lazennec G

FEBS letters 553(3):445-50, 2003 Oct 23 - Who cited this? | PubMed ID: 14572667 | Fulltext

Comparative transductions of breast cancer cells by three DNA viruses.

+ cite this

+ View Abstract

Lucas A, Kremer EJ, Hemmi S, Luis J, Vignon F, and Lazennec G

Biochemical and biophysical research communications 309(4):1011-6, 2003 Oct 3 - Who cited this? | PubMed ID: 13679075 | Fulltext

Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells.

+ cite this

+ View Abstract

Margueron R, Licznar A, Lazennec G, Vignon F, and Cavaillès V

The Journal of endocrinology 179(1):41-53, 2003 Oct - Who cited this? | PubMed ID: 14529564 | Fulltext

IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.

+ cite this

+ View Abstract

Freund A, Chauveau C, Brouillet JP, Lucas A, Lacroix M, Licznar A, Vignon F, and Lazennec G

Oncogene 22(2):256-65, 2003 Jan 16 - Who cited this? | PubMed ID: 12527894 | Fulltext

Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.

+ cite this

+ View Abstract

Moll F, Katsaros D, Lazennec G, Hellio N, Roger P, Giacalone PL, Chalbos D, Maudelonde T, Rochefort H, and Pujol P

Oncogene 21(7):1097-107, 2002 Feb 7 - Who cited this? | PubMed ID: 11850827 | Fulltext

ER beta inhibits proliferation and invasion of breast cancer cells.

+ cite this

+ View Abstract

Lazennec G, Bresson D, Lucas A, Chauveau C, and Vignon F

Endocrinology 142(9):4120-30, 2001 Sep - Who cited this? | PubMed ID: 11517191 | Fulltext

Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators.

+ cite this

+ View Abstract

Lazennec G, Thomas JA, and Katzenellenbogen BS

The Journal of steroid biochemistry and molecular biology 77(4-5):193-203, 2001 Jun - Who cited this? | PubMed ID: 11457657 | Fulltext

Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.

+ cite this

+ View Abstract

Lazennec G, Canaple L, Saugy D, and Wahli W

Molecular endocrinology (Baltimore, Md.) 14(12):1962-75, 2000 Dec - Who cited this? | PubMed ID: 11117527 | Fulltext

Estrogen receptors: selective ligands, partners, and distinctive pharmacology.

+ cite this

+ View Abstract

Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, and Katzenellenbogen JA

Recent progress in hormone research 55:163-93; discussion 194-5, 2000 - Who cited this? | PubMed ID: 11036937 | Fulltext

Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation.

+ cite this

+ View Abstract

Lazennec G, Alcorn JL, and Katzenellenbogen BS

Molecular endocrinology (Baltimore, Md.) 13(6):969-80, 1999 Jun - Who cited this? | PubMed ID: 10379895 | Fulltext

Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.

+ cite this

+ View Abstract

Lazennec G and Katzenellenbogen BS

Molecular and cellular endocrinology 149(1-2):93-105, 1999 Mar 25 - Who cited this? | PubMed ID: 10375022 | Fulltext

The nuclear orphan receptors COUP-TF and ARP-1 positively regulate the trout estrogen receptor gene through enhancing autoregulation.

+ cite this

+ View Abstract

Lazennec G, Kern L, Valotaire Y, and Salbert G

Molecular and cellular biology 17(9):5053-66, 1997 Sep - Who cited this? | PubMed ID: 9271383 | Fulltext

Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.

+ cite this

+ View Abstract

Lazennec G, Ediger TR, Petz LN, Nardulli AM, and Katzenellenbogen BS

Molecular endocrinology (Baltimore, Md.) 11(9):1375-86, 1997 Aug - Who cited this? | PubMed ID: 9259327 | Fulltext

Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.

+ cite this

+ View Abstract

Weis KE, Ekena K, Thomas JA, Lazennec G, and Katzenellenbogen BS

Molecular endocrinology (Baltimore, Md.) 10(11):1388-98, 1996 Nov - Who cited this? | PubMed ID: 8923465 | Fulltext

Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter.

+ cite this

+ View Abstract

Lazennec G, Kern L, Salbert G, Saligaut D, and Valotaire Y

Molecular endocrinology (Baltimore, Md.) 10(9):1116-26, 1996 Sep - Who cited this? | PubMed ID: 8885246 | Fulltext

The sheep estrogen receptor: cloning and regulation of expression in the hypothalamo-pituitary axis.

+ cite this

+ View Abstract

Madigou T, Tiffoche C, Lazennec G, Pelletier J, and Thieulant ML

Molecular and cellular endocrinology 121(2):153-63, 1996 Aug 9 - Who cited this? | PubMed ID: 8892316 | Fulltext

Characterization of the transcription start point of the trout estrogen receptor-encoding gene: evidence for alternative splicing in the 5' untranslated region.

+ cite this

+ View Abstract

Lazennec G, Huignard H, Valotaire Y, and Kern L

Gene 166(2):243-7, 1995 Dec 12 - Who cited this? | PubMed ID: 8543169 | Fulltext

Characterization of an estrogen-responsive element implicated in regulation of the rainbow trout estrogen receptor gene.

+ cite this

+ View Abstract

Le Dréan Y, Lazennec G, Kern L, Saligaut D, Pakdel F, and Valotaire Y

Journal of molecular endocrinology 15(1):37-47, 1995 Aug - Who cited this? | PubMed ID: 8546812 | Fulltext

Search Google Scholar for Lazennec G

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!